Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$51.22 - $60.16 $1.58 Million - $1.86 Million
30,900 Added 140.45%
52,900 $2.79 Million
Q2 2024

Aug 14, 2024

BUY
$47.86 - $75.05 $248,872 - $390,260
5,200 Added 30.95%
22,000 $1.19 Million
Q1 2024

May 15, 2024

SELL
$63.75 - $108.06 $3.26 Million - $5.52 Million
-51,100 Reduced 75.26%
16,800 $1.18 Million
Q4 2023

Feb 14, 2024

BUY
$26.88 - $83.49 $1.83 Million - $5.67 Million
67,900 New
67,900 $5.67 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.62B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.